SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16449697
Source:
http://linkedlifedata.com/resource/pubmed/id/16449697
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013227
,
umls-concept:C0026565
,
umls-concept:C0036341
,
umls-concept:C0040615
pubmed:dateCreated
2006-2-1
pubmed:abstractText
There is an excess of death from natural causes among people with schizophrenia.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16449697-16449698
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16449697-17197667
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0342367
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0007-1250
pubmed:author
pubmed-author:AromaaArpoA
,
pubmed-author:HeliövaaraMarkkuM
,
pubmed-author:JoukamaaMattiM
,
pubmed-author:KnektPaulP
,
pubmed-author:LehtinenVilleV
,
pubmed-author:RaitasaloRaimoR
pubmed:issnType
Print
pubmed:volume
188
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
122-7
pubmed:dateRevised
2007-5-1
pubmed:meshHeading
pubmed-meshheading:16449697-Adult
,
pubmed-meshheading:16449697-Age Distribution
,
pubmed-meshheading:16449697-Aged
,
pubmed-meshheading:16449697-Antipsychotic Agents
,
pubmed-meshheading:16449697-Blood Pressure
,
pubmed-meshheading:16449697-Cholesterol, HDL
,
pubmed-meshheading:16449697-Exercise
,
pubmed-meshheading:16449697-Female
,
pubmed-meshheading:16449697-Finland
,
pubmed-meshheading:16449697-Follow-Up Studies
,
pubmed-meshheading:16449697-Humans
,
pubmed-meshheading:16449697-Life Style
,
pubmed-meshheading:16449697-Male
,
pubmed-meshheading:16449697-Middle Aged
,
pubmed-meshheading:16449697-Polypharmacy
,
pubmed-meshheading:16449697-Population Surveillance
,
pubmed-meshheading:16449697-Prevalence
,
pubmed-meshheading:16449697-Risk Factors
,
pubmed-meshheading:16449697-Schizophrenia
,
pubmed-meshheading:16449697-Sex Distribution
,
pubmed-meshheading:16449697-Smoking
pubmed:year
2006
pubmed:articleTitle
Schizophrenia, neuroleptic medication and mortality.
pubmed:affiliation
Department of Social Psychiatry, Tampere School of Public Health, University of Tampere, FIN-33014, Finland. matti.joukamaa@uta.fi
pubmed:publicationType
Journal Article